Olfr905 Inhibitors
Olfr905, a member of the olfactory receptor family found in Mus musculus (house mouse), plays a crucial role in the olfactory system's function. As with other olfactory receptors, Olfr905 belongs to the class of G-protein-coupled receptors (GPCRs), characterized by its seven-transmembrane domain structure. Its primary function lies in its ability to detect and interact with odorant molecules, initiating a complex cascade of intracellular events that eventually lead to the perception of various odors.
Inhibition of Olfr905 can be accomplished through various mechanisms, both direct and indirect. Direct inhibitors may target the receptor itself, such as by blocking specific receptor sites or disrupting the downstream signaling pathways essential for olfactory signal transduction. Indirect inhibitors, on the other hand, may influence processes related to receptor trafficking, cyclic nucleotide synthesis, or degradation pathways, all of which indirectly impact Olfr905's function in detecting and transmitting olfactory signals. These inhibition mechanisms collectively underscore the intricate and finely tuned regulation of Olfr905 and its pivotal role in the olfactory perception of a wide range of odorous compounds. Understanding the mechanisms of Olfr905 inhibition provides valuable insights into the complex processes underlying olfaction and the molecular basis of odor detection in mice. It highlights the diverse strategies that can be employed to influence olfactory receptor function, contributing to our knowledge of sensory perception in the context of the olfactory system.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Phosphodiesterase inhibitor that increases cAMP levels, disrupting Olfr905 activation by affecting the cyclic nucleotide signaling pathway essential for olfactory signal transduction. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Calmodulin antagonist that interferes with calcium signaling. Reduced intracellular calcium levels impede Olfr905 activation and downstream signal transduction, indirectly suppressing olfactory perception. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that disrupts the degradation of Olfr905. Increased stability of Olfr905 protein results in its accumulation and potential suppression of olfactory signaling. | ||||||
Olanzapine | 132539-06-1 | sc-212469 | 100 mg | $133.00 | 6 | |
GPCR antagonist targeting receptors in the olfactory system. Inhibition of these receptors indirectly dampens Olfr905-mediated signal transduction, leading to reduced olfactory perception. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Microtubule destabilizer that affects olfactory cilia structure. Altered cilia structure impairs Olfr905's membrane localization and its interaction with odorant molecules, hindering olfactory perception. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibitor of the MAPK pathway, a key component of olfactory signal transduction. Disruption of this pathway indirectly suppresses Olfr905 function by impeding downstream signaling events. | ||||||
SQ 22536 | 17318-31-9 | sc-201572 sc-201572A | 5 mg 25 mg | $95.00 $363.00 | 13 | |
Adenylyl cyclase inhibitor that reduces cAMP synthesis. Lower cAMP levels lead to decreased Olfr905 activation and downstream signal transduction, indirectly inhibiting olfactory perception. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Inhibitor of olfactory vesicle trafficking pathways. Impaired vesicle transport indirectly hinders Olfr905 membrane expression, affecting its interaction with odorant molecules and diminishing olfactory perception. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Protein synthesis inhibitor that targets components of the olfactory signaling pathway. Inhibition of protein synthesis indirectly reduces the expression of Olfr905 and its downstream effectors, suppressing olfactory perception. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
Calcium channel blocker that interferes with calcium influx. Reduced intracellular calcium levels indirectly suppress Olfr905 activation and its subsequent role in olfactory signal transduction. | ||||||